AlphaCrest Capital Management’s CareDx CDNA Stock Holding History

AlphaCrest Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,332	Closed	-$567K	–	202
2022 Q3	$567K	Sell	33,332 -836	-2%	-$17.9K	0.03%	922
2022 Q2	$734K	Buy	34,168 +23,067	+208%	+$640K	0.04%	804
2022 Q1	$411K	Buy	11,101 +4,940	+80%	+$193K	0.02%	986
2021 Q4	$280K	Sell	6,161 -1,506	-20%	-$78.6K	0.01%	1271
2021 Q3	$486K	Buy	7,667 +4,223	+123%	+$322K	0.03%	923
2021 Q2	$315K	Sell	3,444 -2,877	-46%	-$229K	0.01%	1088
2021 Q1	$430K	Sell	6,321 -1,893	-23%	-$147K	0.02%	871
2020 Q4	$595K	Sell	8,214 -7,899	-49%	-$458K	0.05%	555
2020 Q3	$611K	Buy	+16,113	New	+$544K	0.07%	472
2019 Q4	–	Sell	-20,600	Closed	-$466K	–	1255
2019 Q3	$466K	Buy	+20,600	New	+$570K	0.03%	940

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

AlphaCrest Capital Management's CDNA Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of CareDx (CDNA) in Q4 2022, closing a stake of 33,332 shares — an estimated $567K sold.

AlphaCrest Capital Management first reported a position in CDNA in Q3 2019 and held it in 10 quarters. The position peaked at $734K in Q2 2022. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

AlphaCrest Capital Management reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 33,332 CareDx shares in Q4 2022, an estimated $567K.
AlphaCrest Capital Management first reported a position in CareDx in Q3 2019 and held it in 10 quarters.
AlphaCrest Capital Management's CareDx position peaked at $734K in Q2 2022.
168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.